$DVAX
DYNAVAX TECHNOLOGIES CORP Stock $dvax

$dvax Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-K Financial Statement

#000156459017004119 Filed on March 13, 2017

Income Statement

Concept	2017 Q1	2015 Q4	2015 Q3
Revenue	$148.0K	$685.0K	$1.188M
YoY Change	-84.29%	-69.92%	-46.22%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.472M	$6.230M	$5.290M
YoY Change	-12.89%	23.37%	25.65%
% of Gross Profit
Research & Development	$16.35M	$20.93M	$24.11M
YoY Change	-18.55%	6.57%	-14.13%
% of Gross Profit
Depreciation & Amortization	$790.0K	$410.0K	$330.0K
YoY Change	97.5%	7.89%	-2.94%
% of Gross Profit
Operating Expenses	$25.60M	$27.16M	$29.63M
YoY Change	-9.34%	10.0%	-8.23%
Operating Profit	-$25.45M
YoY Change	-6.75%
Interest Expense	$150.0K	$130.0K	$62.00K
YoY Change	-34.78%	-1400.0%	55.0%
% of Operating Profit
Other Income/Expense, Net	$20.00K	-$40.00K	$17.00K
YoY Change	-56.52%	-130.77%	-92.13%
Pretax Income	-$25.29M	-$26.86M	-$30.12M
YoY Change	-6.4%	20.5%	1.01%
Income Tax
% Of Pretax Income
Net Earnings	-$25.29M	-$26.86M	-$30.12M
YoY Change	-6.42%	20.53%	1.02%
Net Earnings / Revenue	-17085.81%	-3921.46%	-2535.69%
Basic Earnings Per Share
Diluted Earnings Per Share	-$604.6K	-$510.1K	-$824.5K
COMMON SHARES
Basic Shares Outstanding	44.35M
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q1	2015 Q4	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$85.40M	$196.1M	$220.7M
YoY Change	-48.8%	59.9%	68.99%
Cash & Equivalents	$21.47M	$44.81M	$103.0M
Short-Term Investments	$63.90M	$151.3M	$117.7M
Other Short-Term Assets	$2.800M	$2.400M	$2.500M
YoY Change	3.7%	-41.46%	-30.56%
Inventory
Prepaid Expenses
Receivables	$1.500M	$1.400M	$1.200M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$89.70M	$199.9M	$224.3M
YoY Change	-47.45%	56.9%	66.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.60M	$13.80M	$11.60M
YoY Change	4.4%	74.73%	43.21%
Goodwill		$2.043M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.800M	$231.0K	$800.0K
YoY Change	100.0%	-67.0%	-46.67%
Total Long-Term Assets	$20.40M	$16.69M	$14.60M
YoY Change	7.94%	53.61%	21.67%
TOTAL ASSETS
Total Short-Term Assets	$89.70M	$199.9M	$224.3M
Total Long-Term Assets	$20.40M	$16.69M	$14.60M
Total Assets	$110.1M	$216.6M	$238.9M
YoY Change	-41.93%	56.64%	62.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.500M	$3.433M	$2.400M
YoY Change	-57.14%	186.08%	-52.0%
Accrued Expenses	$10.90M	$15.34M	$13.80M
YoY Change	-43.52%	142.79%	13.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.40M	$28.80M	$19.70M
YoY Change	-49.39%	42.02%	-13.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$358.0K	$800.0K	$8.000M
YoY Change	-48.86%	-25.23%	220.0%
Total Long-Term Liabilities	$358.0K	$800.0K	$8.000M
YoY Change	-48.86%	-92.47%	220.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.40M	$28.80M	$19.70M
Total Long-Term Liabilities	$358.0K	$800.0K	$8.000M
Total Liabilities	$12.74M	$29.60M	$27.70M
YoY Change	-49.46%	-21.71%	9.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$837.5M	-$699.7M
YoY Change	15.23%
Common Stock	$938.2M	$889.7M	$886.6M
YoY Change	5.03%	28.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$97.40M	$187.1M	$211.2M
YoY Change
Total Liabilities & Shareholders Equity	$110.1M	$216.6M	$238.9M
YoY Change	-41.93%	56.64%	62.63%

Cashflow Statement

Concept	2017 Q1	2015 Q4	2015 Q3
OPERATING ACTIVITIES
Net Income	-$25.29M	-$26.86M	-$30.12M
YoY Change	-6.42%	20.53%	1.02%
Depreciation, Depletion And Amortization	$790.0K	$410.0K	$330.0K
YoY Change	97.5%	7.89%	-2.94%
Cash From Operating Activities	-$25.25M	-$21.85M	-$23.00M
YoY Change	-6.93%	29.52%	-0.39%
INVESTING ACTIVITIES
Capital Expenditures	$234.0K	-$2.720M	-$2.580M
YoY Change	-91.04%	491.3%	789.66%
Acquisitions
YoY Change
Other Investing Activities	-$6.780M	-$33.83M	-$60.93M
YoY Change	-129.02%	-190.05%	-333.0%
Cash From Investing Activities	-$7.010M	-$36.56M	-$63.50M
YoY Change	-133.78%	-198.52%	-345.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$29.54M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	29.39M	300.0K	153.0M
YoY Change	8544.12%	-96.93%	254916.67%
NET CHANGE
Cash From Operating Activities	-25.25M	-21.85M	-23.00M
Cash From Investing Activities	-7.010M	-36.56M	-63.50M
Cash From Financing Activities	29.39M	300.0K	153.0M
Net Change In Cash	-2.814M	-58.11M	66.51M
YoY Change	-53.41%	-293.7%	2241.9%
FREE CASH FLOW
Cash From Operating Activities	-$25.25M	-$21.85M	-$23.00M
Capital Expenditures	$234.0K	-$2.720M	-$2.580M
Free Cash Flow	-$25.48M	-$19.13M	-$20.42M
YoY Change	-14.31%	16.58%	-10.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016Q2	dei	Entity Public Float EntityPublicFloat	409000000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44812000
CY2015Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	151313000
CY2016Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1342000
CY2015Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1394000
CY2015Q4	us-gaap	Assets Current AssetsCurrent	199946000
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44352830
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13804000
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15337000
CY2015Q4	us-gaap	Goodwill Goodwill	2043000
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	609000
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	231000
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3433000
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2427000
CY2015Q4	dvax	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	7361000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9703000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	100482000
CY2014	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	130000
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92243000
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Trading Symbol TradingSymbol	DVAX
CY2016	dei	Entity Registrant Name EntityRegistrantName	DYNAVAX TECHNOLOGIES CORP
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001029142
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-90722000
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1553000
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	32000
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26289000
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1521000
CY2015Q4	us-gaap	Assets Assets	216633000
CY2014	us-gaap	Interest Expense InterestExpense	35000
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	433000
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.45
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1671000
CY2014	us-gaap	Business Exit Costs1 BusinessExitCosts1	386000
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	186294000
CY2014	dvax	Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue	49000
CY2014	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	130000
CY2014	dvax	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	163000
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6089000
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2000
CY2015	dvax	Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue	531000
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	183897000
CY2015	dvax	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	228000
CY2016	dvax	Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue	-83000
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	615000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14728000
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2257000
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1365000
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1404000
CY2016	dvax	Write Off Of Assets In Progress WriteOffOfAssetsInProgress	862000
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-91000
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-46000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	9316000
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	6089000
CY2015	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	667000
CY2014	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-900000
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2683000
CY2014	dvax	Increase Decrease In Restricted Cash And Other Assets For Operating Activities IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities	-277000
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1667000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-85796000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	90597000
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	183897000
CY2015	us-gaap	Repayments Of Debt RepaymentsOfDebt	10988000
CY2016	dvax	Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net WithholdingsProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet	-84000
CY2015	dvax	Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net WithholdingsProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet	531000
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	24000
CY2016	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-178000
CY2015	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-660000
CY2014	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-881000
CY2015	dvax	Accretion Of Debt Discounts Related To Debt Financing AccretionOfDebtDiscountsRelatedToDebtFinancing	-115000
CY2016	dvax	Cash Settled Portion Of Stock Based Compensation Expense CashSettledPortionOfStockBasedCompensationExpense	602000
CY2015	dvax	Cash Settled Portion Of Stock Based Compensation Expense CashSettledPortionOfStockBasedCompensationExpense	387000
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-523000
CY2014	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4810000
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-10111000
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	5467000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-92559000
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-73738000
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	208936000
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	44807000
CY2015	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	130110000
CY2014	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	137071000
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6970000
CY2014	dvax	Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net WithholdingsProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet	49000
CY2015	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	228000
CY2014	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	163000
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9559000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	531000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	173959000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	9901000
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-252000
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-303000
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-371000
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-20523000
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4699000
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	26389000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49511000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23122000
CY2015	us-gaap	Interest Paid InterestPaid	720000
CY2016	dvax	Accrual For Litigation Settlement And Insurance Recovery AccrualForLitigationSettlementAndInsuranceRecovery	4975000
CY2015	dvax	Supplemental Disposal Of Assets SupplementalDisposalOfAssets	1436000
CY2014	dvax	Supplemental Disposal Of Assets SupplementalDisposalOfAssets	841000
CY2016Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	81400000
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2016	us-gaap	Business Acquisition Description Of Acquired Entity BusinessAcquisitionDescriptionOfAcquiredEntity	In April 2006, we completed the acquisition of Dynavax GmbH, a wholly-owned subsidiary in Düsseldorf, Germany.
CY2016	us-gaap	Business Acquisition Effective Date Of Acquisition1 BusinessAcquisitionEffectiveDateOfAcquisition1	2006-04-30
CY2016	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2014	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2016Q4	us-gaap	Fair Value Equity Level1 To Level2 Transfers Amount FairValueEquityLevel1ToLevel2TransfersAmount	0
CY2015Q4	us-gaap	Fair Value Equity Level1 To Level2 Transfers Amount FairValueEquityLevel1ToLevel2TransfersAmount	0
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	81411000
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	196113000
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	78000
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4000
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	81415000
CY2016Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	4975000
CY2015Q4	dvax	Accrued Third Party Research Expenses Current AccruedThirdPartyResearchExpensesCurrent	5241000
CY2015Q4	dvax	Accrued Third Party Development Expenses Current AccruedThirdPartyDevelopmentExpensesCurrent	2072000
CY2015Q4	dvax	Accrued Return Of Unused Development Funding To Affiliate Current AccruedReturnOfUnusedDevelopmentFundingToAffiliateCurrent	7345000
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1972000
CY2015Q4	dvax	Accrued Research And Development Expenses And Accrued Liabilities Current AccruedResearchAndDevelopmentExpensesAndAccruedLiabilitiesCurrent	22698000
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2200000
CY2016Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	300000
CY2016	us-gaap	Gain Loss On Sale Of Leased Assets Net Operating Leases GainLossOnSaleOfLeasedAssetsNetOperatingLeases	-300000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2560000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1491000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	638000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	644000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	515000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	561000
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6409000
CY2016	us-gaap	Loss Contingency Settlement Agreement Date LossContingencySettlementAgreementDate	September 7, 2016
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4673000
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2015Q4	dvax	Number Of Warrants Exercised During Period NumberOfWarrantsExercisedDuringPeriod	383000
CY2014Q4	dvax	Number Of Warrants Exercised During Period NumberOfWarrantsExercisedDuringPeriod	11000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	12100000
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6900000
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	5600000
CY2016	dvax	Share Based Compensation Arrangement By Share Based Payment Award Options And Rsu Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber	70000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	26285000
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14126000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	8684000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	9771000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-106794000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-90722000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-38183000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-36301000
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-30818000
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-334000
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-394000
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1204000
CY2016	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1950000
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	2622000
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1484000
CY2016	dvax	Income Tax Reconciliation Deferred Compensation Charges IncomeTaxReconciliationDeferredCompensationCharges	3016000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9316000
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6089000
CY2014	dvax	Cash Settled Portion Of Stock Based Compensation Expense CashSettledPortionOfStockBasedCompensationExpense	0
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	500000
CY2016	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	200000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-114484000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-107450000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-91121000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2040000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	656000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	399000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-112444000
CY2015	dvax	Income Tax Reconciliation Deferred Compensation Charges IncomeTaxReconciliationDeferredCompensationCharges	1481000
CY2014	dvax	Income Tax Reconciliation Deferred Compensation Charges IncomeTaxReconciliationDeferredCompensationCharges	2710000
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	36751000
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	36766000
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	28093000
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	700000
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1070000
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	295000
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	249510000
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	212074000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	29463000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4457000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	6553000
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	908000
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1303000
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1375000
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	293417000
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	256966000
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	293145000
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	256712000
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	272000
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	254000
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	272000
CY2015Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	254000
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	272000
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	36532000
CY2015Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	38429000
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	254000
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	36400000
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	36200000
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	27800000
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2426000
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2426000
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2400000
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0
CY2016	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2016	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0
CY2016Q1	us-gaap	Revenues Revenues	942000
CY2016Q2	us-gaap	Revenues Revenues	2647000
CY2016Q3	us-gaap	Revenues Revenues	162000
CY2016Q4	us-gaap	Revenues Revenues	7292000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-27023000
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-28986000
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-34694000
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-21741000
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.75
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.90
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.56
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	38472000
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	38496000
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	38512000
CY2016Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	38544000
CY2015Q1	us-gaap	Revenues Revenues	627000
CY2015Q2	us-gaap	Revenues Revenues	1550000
CY2015Q3	us-gaap	Revenues Revenues	1188000
CY2015Q4	us-gaap	Revenues Revenues	685000
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-26217000
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-23591000
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-30124000
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-26862000
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.97
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.80
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.82
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27065000
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29335000

Files In Submission

Name	View Source	Status
0001564590-17-004119-index-headers.html	Edgar Link	pending
0001564590-17-004119-index.html	Edgar Link	pending
0001564590-17-004119.txt	Edgar Link	pending
0001564590-17-004119-xbrl.zip	Edgar Link	pending
dvax-10k_20161231.htm	Edgar Link	pending
dvax-20161231.xml	Edgar Link	completed
dvax-20161231.xsd	Edgar Link	pending
dvax-20161231_cal.xml	Edgar Link	unprocessable
dvax-20161231_def.xml	Edgar Link	unprocessable
dvax-20161231_lab.xml	Edgar Link	unprocessable
dvax-20161231_pre.xml	Edgar Link	unprocessable
dvax-ex1028_458.htm	Edgar Link	pending
dvax-ex1029_239.htm	Edgar Link	pending
dvax-ex121_9.htm	Edgar Link	pending
dvax-ex211_6.htm	Edgar Link	pending
dvax-ex231_12.htm	Edgar Link	pending
dvax-ex311_8.htm	Edgar Link	pending
dvax-ex312_10.htm	Edgar Link	pending
dvax-ex321_13.htm	Edgar Link	pending
dvax-ex322_7.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DVAX
DYNAVAX TECHNOLOGIES CORP Stock $dvax

2017 Q1 Form 10-K Financial Statement

#000156459017004119 Filed on March 13, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DVAX DYNAVAX TECHNOLOGIES CORP Stock $dvax

2017 Q1 Form 10-K Financial Statement

#000156459017004119 Filed on March 13, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DVAX
DYNAVAX TECHNOLOGIES CORP Stock $dvax